News Archives - Page 183 of 741

FridayJul 28, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for the REQORSA-Keytruda drug combination in the U.S., Japan, Australia, Russia, Mexico, and China, meaning the company has secured exclusivity in many of the largest markets The granted patents, three Fast Track Designations, and positive preclinical…

FridayJul 28, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Newly Granted Patent for DehydraTECH(TM)–Nicotine by United States Patent and Trademark Office

Lexaria’s new patent includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches The global oral nicotine pouch market was valued at $4.69 billion in 2022 and is expected to grow to $11.91 billion by 2029, driven by the growing ban on e-cigarettes worldwide The white pouch category is one of the fastest-growing, tobacco-free alternatives to smoking and vaping – growing at a CAGR of 13.4% Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that the United…

ThursdayJul 27, 2023 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Keeping a Close Eye on FMCSA Speed Limiter Rule, Amid Growing Debate and Displeasure from OOIDA

The FMCSA (Federal Motor Carrier Safety Administration) proposed a rule mandating speed limiters for most commercial vehicles The ATA has supported the move, while OOIDA (Owner Operator Independent Drivers Association) has opposed it, terming it as an attempt to eliminate one of the few advantages they enjoy over big business The FMCSA is yet to communicate its decision on the matter, pending its review of over 15,000 comments on the issue Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility, and simplicity, is…

ThursdayJul 27, 2023 9:00 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Poised to Benefit as Silver Stocks Slip into Deep Deficit

Global ambitions to achieve net zero status will necessitate a near tripling in annual clean energy investment Silver has emerged as a critical component of clean energy infrastructure due to its exceptional electric and thermal conductivity Nevertheless, a decrease in global silver production coupled with rising demand has left the precious metal in deficit – with the market undersupplied by nearly 238mn tonnes in 2022 Eloro Resources’ Iska Iska deposit may be poised to emerge as a rare greenfield silver project with the company set to publish its inaugural NI 43-101 compliant mineral resource estimate Global warming has become an…

WednesdayJul 26, 2023 10:30 am

DGE’s 3rd Diversity, Equity & Inclusion for Pharma & Healthcare Summit

DGE invites life science Diversity, Equity & Inclusion (“DEI”) practitioners, health equity advocates, HR executives, and health policy leaders, to attend the 3rd Advancing Diversity, Equity & Inclusion in Pharma & Healthcare Summit to be held at the Hyatt Bellevue, Philadelphia, PA, on September 19-20, 2023. The industry’s leading event will focus on putting developing policies into practices including novel case studies and sessions on important areas. The leading DEI event for Pharma & Healthcare serves as a dynamic platform for industry leaders, advocates, practitioners and influencers to convene, work toward common goals and drive the life science ecosystem toward…

WednesdayJul 26, 2023 9:45 am

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive agreement to acquire DICE Therapeutics for approximately $2.4 billion as evidence of the potential value of BiondVax in this segment of the therapeutics market DICE Therapeutics is currently evaluating its lead drug candidate, DC-806, an oral IL-17 inhibitor, in a Phase II trial, with early-stage results from the Phase I study showing a near-44% reduction in Psoriasis Area and Severity Index The…

WednesdayJul 26, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Set to be Used in Multi-Billion Dollar Markets; On Track to have 2023 as Best Year Yet

Lexaria’s patented DehydraTECH(TM) technology enhances the performance of several categories of fat-soluble active molecules and drugs across oral and/or topical product formats This unique approach to drug delivery has earned Lexaria a total of 35 patents, with many patents pending worldwide The company continues active discussions with multi-billion dollar companies for the potential use of DehydraTECH in their commercial pursuits Lexaria is also actively seeking commercial partners during 2023 and 2024 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is out on an ambitious move to address conditions with high unmet needs. This focus has allowed them…

TuesdayJul 25, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Accelerates Commercial Quantum Adoption As Business and Government Interest in Quantum Computing Grows

D-Wave is working with a portfolio of impressive commercial customers including Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, and many more Governments worldwide are calling for the implementation of quantum applications – with the United States pushing for development and deployment of quantum applications within the next 24 months D-Wave, the world’s first commercial quantum computing solutions supplier, is successfully filling the increasing quantum needs of customers along with the growing interest of the government for expanding quantum technology D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and…

TuesdayJul 25, 2023 9:00 am

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Reports Promising Results from Texmont Project Amid Forecast of Growing Demand

Report projects that demand for nickel from the battery industry is set to increase significantly Texmont testing delivers results that meet or exceed expectations The company has acquired 403 additional mining claims within the Texmont ultramafic trend With experts predicting that nickel metal will play a key role in the 2023 battery-grade market (https://ibn.fm/e8Ky4), Canada Nickel Company (TSX.V: CNC) (OTCQX: CNIKF) appears to be ideally positioned in the growing space. The company just released initial results from preliminary metallurgical testing at its Texmont Nickel Sulphide Project, and the results meet or exceed historical results (https://ibn.fm/NpwuL). Nickel metal has a key…

Site Search

Company Search

Category: News